<p>联合健康集团 (NYSE:UNH - 获取免费报告) 在周三发布的研究报告中，皇家银行的股票研究人员将其目标价格从 355.00 美元下调至 286.00 美元，Benzinga 报道。该经纪公司目前对这家医疗保健综合体的股票给予 &#34;跑赢大盘&#34; 的评级。皇家银行的价格目标表明，与该股票之前的收盘价相比，存在 9.84% 的潜在上涨空间。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<ul>
<li>HCA 医疗保健能否复兴市场最疲软的行业？</li>
</ul>
<p>其他几位研究分析师也最近对 UNH 发表了看法。雷蒙德·詹姆斯金融公司在 5 月 14 日的研究报告中将联合健康集团的评级从 &#34;强力买入&#34; 下调至 &#34;市场表现&#34;。巴克莱在 7 月 17 日的报告中重申了对联合健康集团股票的 &#34;增持&#34; 评级。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 &#34;买入&#34; 评级。瑞穗证券在 5 月 16 日的报告中将联合健康集团的目标价格从 515.00 美元下调至 350.00 美元，并对该公司给予 &#34;跑赢大盘&#34; 的评级。最后，Erste Group Bank 在 4 月 30 日的研究报告中将联合健康集团的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。一位投资分析师对该股票给予了卖出评级，九位给予了持有评级，十五位给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，共识目标价格为 378.95 美元。</p>
<p><strong>查看我们关于 UNH 的最新股票报告</strong></p>
<h2>联合健康集团股票下跌 0.3%</h2>
<ul>
<li>医疗保健股票触及估值底部，3 个名字有望反弹</li>
</ul>
<p>周三交易时段，NYSE UNH 的股票下跌 0.69 美元，报 260.38 美元。该公司的交易量为 7,638,810 股，而其平均交易量为 11,566,953 股。该股票的市值为 2362 亿美元，市盈率为 10.89，市盈增长比率为 1.40，贝塔系数为 0.45。该公司的速动比率为 0.85，流动比率为 0.85，债务股本比率为 0.71。联合健康集团的 1 年低点为 248.88 美元，1 年高点为 630.73 美元。该公司的 50 日移动平均线为 299.69 美元，200 日移动平均线为 421.43 美元。</p>
<p>联合健康集团 (NYSE:UNH - 获取免费报告) 最近于 7 月 29 日宣布了其季度财报。这家医疗保健综合体报告本季度每股收益 (EPS) 为 4.08 美元，低于共识预期的 5.16 美元，差额为 1.08 美元。联合健康集团的净利润率为 5.39%，股本回报率为 26.29%。该公司本季度的收入为 1116.2 亿美元，而分析师预期为 1117.5 亿美元。在去年同期，该公司的每股收益为 6.80 美元。与去年同期相比，该公司的季度收入增长了 12.9%。分析师预计联合健康集团在当前财政年度的每股收益将达到 29.54 美元。</p>
<h2>内部买卖</h2>
<ul>
<li>内部人士在过去两个月花费数百万购买这 3 只股票</li>
</ul>
<p>在其他联合健康集团的新闻中，首席执行官帕特里克·休·康威在 6 月 10 日的交易中出售了 589 股公司的股票。该股票以平均价格 305.00 美元出售，总价值为 179,645.00 美元。出售后，首席执行官持有公司股票 10,398 股，价值 3,171,390 美元。此次交易使其持股减少了 5.36%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，首席执行官斯蒂芬·J·赫姆斯利在 5 月 16 日的交易中购买了 86,700 股公司的股票。该股票以每股平均成本 288.57 美元购买，总交易额为 25,019,019.00 美元。交易后，首席执行官持有公司股票 679,493 股，价值 196,081,295.01 美元。这笔交易使其持股增加了 14.63%。该购买的披露信息可以在此找到。内部人士在上个季度共购买了价值 31,607,768 美元的 109,408 股公司股票。0.28% 的股票由内部人士持有。</p>
<h2>联合健康集团的机构交易</h2>
<p>大型投资者最近调整了对该股票的持有。Marshall &amp; Sterling Wealth Advisors Inc. 在第四季度购买了联合健康集团的新股份，价值 26,000 美元。Hurley Capital LLC 在第四季度获得了联合健康集团的新职位，价值 28,000 美元。Bayforest Capital Ltd 在第一季度将其在联合健康集团的股份增加了 685.7%。Bayforest Capital Ltd 目前持有 55 股这家医疗保健综合体的股票，价值 29,000 美元，此前在上个季度又购买了 48 股。Aster Capital Management DIFC Ltd 在第四季度获得了联合健康集团的新职位，价值 30,000 美元。最后，Clal Insurance Enterprises Holdings Ltd 在第一季度将其在联合健康集团的股份增加了 416.7%。Clal Insurance Enterprises Holdings Ltd 目前持有 62 股这家医疗保健综合体的股票，价值 32,000 美元，此前在上个季度又购买了 50 股。对冲基金和其他机构投资者持有该公司 87.86% 的股票。</p>
<h2>联合健康集团公司简介</h2>
<p>(获取免费报告)</p>
<p>联合健康集团是一家在美国运营的多元化医疗保健公司。该公司通过四个部门运营：UnitedHealthcare、Optum Health、Optum Insight 和 Optum Rx。UnitedHealthcare 部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的群体提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
<h2>另见</h2>
<ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>消费者非必需品股票解析</li>
<li>3 只适合长期持有的优秀成长股</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>NVIDIA：一个主要指标刚刚发出卖出信号，但你应该买吗？</li>
<li>价值投资：在 2022 年这是一个好策略吗？提示：永远</li>
<li>为什么可口可乐股票今天是交易者的首选</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
<p>在考虑联合健康集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康集团并不在名单上。</p>
<p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

<p>加拿大皇家银行已将联合健康集团（NYSE: UNH）的目标价格从 355 美元下调至 286 美元，维持 “跑赢大盘” 的评级。这一调整表明，相较于该股之前的收盘价，存在 9.84% 的潜在上涨空间。其他分析师也对其评级进行了调整，普遍目标价格为 378.95 美元。联合健康的股票最近交易价格为 260.38 美元，反映出 0.3% 的下跌。该公司报告每股收益为 4.08 美元，未达到预期，季度收入为 1116.2 亿美元，同比增长 12.9%</p>

<p>UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price lowered by equities researchers at Royal Bank Of Canada from $355.00 to $286.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an &#34;outperform&#34; rating on the healthcare conglomerate's stock. Royal Bank Of Canada's price objective indicates a potential upside of 9.84% from the stock's previous close.</p>
<div class="lb-trans"><p>联合健康集团 (NYSE:UNH - 获取免费报告) 在周三发布的研究报告中，皇家银行的股票研究人员将其目标价格从 355.00 美元下调至 286.00 美元，Benzinga 报道。该经纪公司目前对这家医疗保健综合体的股票给予 &#34;跑赢大盘&#34; 的评级。皇家银行的价格目标表明，与该股票之前的收盘价相比，存在 9.84% 的潜在上涨空间。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA 医疗保健能否复兴市场最疲软的行业？</li>
</ul>
</div><p>Several other research analysts have also recently weighed in on UNH. Raymond James Financial cut UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;market perform&#34; rating in a research report on Wednesday, May 14th. Barclays reiterated an &#34;overweight&#34; rating on shares of UnitedHealth Group in a report on Thursday, July 17th. UBS Group reiterated a &#34;buy&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Mizuho reduced their target price on UnitedHealth Group from $515.00 to $350.00 and set an &#34;outperform&#34; rating for the company in a report on Friday, May 16th. Finally, Erste Group Bank downgraded UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $378.95.</p>
<div class="lb-trans"><p>其他几位研究分析师也最近对 UNH 发表了看法。雷蒙德·詹姆斯金融公司在 5 月 14 日的研究报告中将联合健康集团的评级从 &#34;强力买入&#34; 下调至 &#34;市场表现&#34;。巴克莱在 7 月 17 日的报告中重申了对联合健康集团股票的 &#34;增持&#34; 评级。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 &#34;买入&#34; 评级。瑞穗证券在 5 月 16 日的报告中将联合健康集团的目标价格从 515.00 美元下调至 350.00 美元，并对该公司给予 &#34;跑赢大盘&#34; 的评级。最后，Erste Group Bank 在 4 月 30 日的研究报告中将联合健康集团的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。一位投资分析师对该股票给予了卖出评级，九位给予了持有评级，十五位给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，共识目标价格为 378.95 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on UNH</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 UNH 的最新股票报告</strong></p>
</div><h2>UnitedHealth Group Stock Down 0.3%</h2>
<div class="lb-trans"><h2>联合健康集团股票下跌 0.3%</h2>
</div><ul>
<li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保健股票触及估值底部，3 个名字有望反弹</li>
</ul>
</div><p>Shares of NYSE UNH traded down $0.69 during trading hours on Wednesday, hitting $260.38. The company had a trading volume of 7,638,810 shares, compared to its average volume of 11,566,953. The stock has a market capitalization of $236.20 billion, a P/E ratio of 10.89, a price-to-earnings-growth ratio of 1.40 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group has a 1-year low of $248.88 and a 1-year high of $630.73. The firm's 50 day moving average is $299.69 and its 200-day moving average is $421.43.</p>
<div class="lb-trans"><p>周三交易时段，NYSE UNH 的股票下跌 0.69 美元，报 260.38 美元。该公司的交易量为 7,638,810 股，而其平均交易量为 11,566,953 股。该股票的市值为 2362 亿美元，市盈率为 10.89，市盈增长比率为 1.40，贝塔系数为 0.45。该公司的速动比率为 0.85，流动比率为 0.85，债务股本比率为 0.71。联合健康集团的 1 年低点为 248.88 美元，1 年高点为 630.73 美元。该公司的 50 日移动平均线为 299.69 美元，200 日移动平均线为 421.43 美元。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business earned $6.80 EPS. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>联合健康集团 (NYSE:UNH - 获取免费报告) 最近于 7 月 29 日宣布了其季度财报。这家医疗保健综合体报告本季度每股收益 (EPS) 为 4.08 美元，低于共识预期的 5.16 美元，差额为 1.08 美元。联合健康集团的净利润率为 5.39%，股本回报率为 26.29%。该公司本季度的收入为 1116.2 亿美元，而分析师预期为 1117.5 亿美元。在去年同期，该公司的每股收益为 6.80 美元。与去年同期相比，该公司的季度收入增长了 12.9%。分析师预计联合健康集团在当前财政年度的每股收益将达到 29.54 美元。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Insiders Spent Millions on These 3 Stocks Over the Past 2 Months</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士在过去两个月花费数百万购买这 3 只股票</li>
</ul>
</div><p>In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. 0.28% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他联合健康集团的新闻中，首席执行官帕特里克·休·康威在 6 月 10 日的交易中出售了 589 股公司的股票。该股票以平均价格 305.00 美元出售，总价值为 179,645.00 美元。出售后，首席执行官持有公司股票 10,398 股，价值 3,171,390 美元。此次交易使其持股减少了 5.36%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。此外，首席执行官斯蒂芬·J·赫姆斯利在 5 月 16 日的交易中购买了 86,700 股公司的股票。该股票以每股平均成本 288.57 美元购买，总交易额为 25,019,019.00 美元。交易后，首席执行官持有公司股票 679,493 股，价值 196,081,295.01 美元。这笔交易使其持股增加了 14.63%。该购买的披露信息可以在此找到。内部人士在上个季度共购买了价值 31,607,768 美元的 109,408 股公司股票。0.28% 的股票由内部人士持有。</p>
</div><h2>Institutional Trading of UnitedHealth Group</h2>
<div class="lb-trans"><h2>联合健康集团的机构交易</h2>
</div><p>Large investors have recently modified their holdings of the stock. Marshall &amp; Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $28,000. Bayforest Capital Ltd grew its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近调整了对该股票的持有。Marshall &amp; Sterling Wealth Advisors Inc. 在第四季度购买了联合健康集团的新股份，价值 26,000 美元。Hurley Capital LLC 在第四季度获得了联合健康集团的新职位，价值 28,000 美元。Bayforest Capital Ltd 在第一季度将其在联合健康集团的股份增加了 685.7%。Bayforest Capital Ltd 目前持有 55 股这家医疗保健综合体的股票，价值 29,000 美元，此前在上个季度又购买了 48 股。Aster Capital Management DIFC Ltd 在第四季度获得了联合健康集团的新职位，价值 30,000 美元。最后，Clal Insurance Enterprises Holdings Ltd 在第一季度将其在联合健康集团的股份增加了 416.7%。Clal Insurance Enterprises Holdings Ltd 目前持有 62 股这家医疗保健综合体的股票，价值 32,000 美元，此前在上个季度又购买了 50 股。对冲基金和其他机构投资者持有该公司 87.86% 的股票。</p>
</div><h2>UnitedHealth Group Company Profile</h2>
<div class="lb-trans"><h2>联合健康集团公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团是一家在美国运营的多元化医疗保健公司。该公司通过四个部门运营：UnitedHealthcare、Optum Health、Optum Insight 和 Optum Rx。UnitedHealthcare 部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的群体提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>3 Great Growth Stocks to Buy-and-Hold for the Next 10 Years</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>NVIDIA: A Major Indicator Just Flashed Sell, But Should You?</li>
<li>Value Investing: Is it a Good Strategy in 2022? Hint: Always</li>
<li>Why Coca-Cola Stock Is a Top Pick for Traders Today</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>消费者非必需品股票解析</li>
<li>3 只适合长期持有的优秀成长股</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>NVIDIA：一个主要指标刚刚发出卖出信号，但你应该买吗？</li>
<li>价值投资：在 2022 年这是一个好策略吗？提示：永远</li>
<li>为什么可口可乐股票今天是交易者的首选</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康集团并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

加拿大皇家银行发布了对联合健康集团（NYSE:UNH）股票价格的悲观预测